Clinical Trial Update: Target-specific immunoPET Imaging of Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/Phase 2 clinical trial evaluating a target-specific immunoPET imaging agent for breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: RenJi Hospital | Conditions: Breast Cancer, Breast Neoplasms | Phase 1, Phase 2 | Status: RECRUITING